| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$26,857,607 |
|
|
|
Indirect Value
|
$94,141,463 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$120,999,070 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2021-01-04 |
4 |
AS |
$136.90 |
$4,107,000 |
I/I |
(30,000) |
2,329,741 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-11-02 |
4 |
AS |
$96.82 |
$2,904,600 |
I/I |
(30,000) |
2,359,741 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-09-01 |
4 |
AS |
$82.63 |
$2,478,900 |
I/I |
(30,000) |
2,389,741 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-07-13 |
4 |
AS |
$85.35 |
$3,414,000 |
I/I |
(40,000) |
2,419,741 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
See RemarksOfficer |
• • • |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,552,241 |
|
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2017-08-28 |
4 |
B |
$52.40 |
$393,922 |
I/I |
7,500 |
2,559,741 |
2.66 |
- |
|
106 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
